Literature DB >> 4614950

A double-blind controlled study of viloxazine and imipramine in depression.

I K Tsegos, M Y Ekdawi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4614950     DOI： 10.1185/03007997409115242

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  4 in total

Review 1.  Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-06       Impact factor: 9.546

2.  Blood level studies with viloxazine hydrochloride in man.

Authors:  P F Bayliss; D E Case
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

3.  Unwanted symptoms in depressed patients treated with viloxazine: an algorithm for identification of illness-related symptoms.

Authors:  I Maistrello; G Grassi; A Bertolino; P Valerio; G Pistollato; S Soverini
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Acute effects of viloxazine HCl and flurazepam when given alone and in combination on sleep EEG: a double-blind interaction study with normals.

Authors:  W H Wilson; F R Freemon; T A Ban; W M Petrie; C L Clinton
Journal:  Pavlov J Biol Sci       Date:  1980 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.